Orthofix Medical Inc. Other Nonrecurring (Income) Expense
Orthofix Medical Inc. (OFIX) reported Other Nonrecurring (Income) Expense of -$41.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherNonrecurringIncomeExpense · last filed 2024-05-07
- Orthofix Medical Inc. other nonrecurring (income) expense for the quarter ending 2024-03-31 was -$41.00K.
- Orthofix Medical Inc. other nonrecurring (income) expense for the quarter ending 2023-09-30 was -$92.00K, a 255.93% decline year-over-year.
- Orthofix Medical Inc. other nonrecurring (income) expense for the quarter ending 2023-06-30 was $262.00K, a 38.62% increase year-over-year.
- Orthofix Medical Inc. other nonrecurring (income) expense for the quarter ending 2022-09-30 was $59.00K.
| Period end | Other Nonrecurring (Income) Expense 3 month | Other Nonrecurring (Income) Expense 6 month | Other Nonrecurring (Income) Expense 9 month |
|---|---|---|---|
| 2024-03-31 | -$41.00K 10-Q · filed 2024-05-07 | ||
| 2023-09-30 | -$92.00K 10-Q · filed 2023-11-08 | $170.00K derived: sum of 2 quarters · filed 2023-11-08 | $170.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $262.00K 10-Q · filed 2023-08-08 | $262.00K 10-Q · filed 2023-08-08 | |
| 2022-09-30 | $59.00K 10-Q · filed 2023-11-08 | $248.00K derived: sum of 2 quarters · filed 2023-11-08 | $230.00K 10-Q · filed 2023-11-08 |
| 2022-06-30 | $189.00K 10-Q · filed 2023-08-08 | $266.00K 10-Q · filed 2023-08-08 | |
| 2022-03-31 | $75.00K 10-Q · filed 2023-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |